![5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/96376398-fbed-4daa-bd31-dd6b9854d8fc/gr3.jpg)
5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology
![Many non-small cell lung cancer Medicare patients not staged according to guidelines, leading to higher mortality rates Many non-small cell lung cancer Medicare patients not staged according to guidelines, leading to higher mortality rates](https://scx2.b-cdn.net/gfx/news/2023/nearly-half-of-medicar.jpg)
Many non-small cell lung cancer Medicare patients not staged according to guidelines, leading to higher mortality rates
![A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health](https://www.thelancet.com/cms/asset/0fbe43e7-b69c-43d2-bff9-10ce650542f3/gr1.jpg)
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
![Modern Radiation Further Improves Survival in Non-Small Cell Lung Cancer: An Analysis of 288,670 Patients Modern Radiation Further Improves Survival in Non-Small Cell Lung Cancer: An Analysis of 288,670 Patients](https://www.jcancer.org/v10/p0168/jcav10p0168g001.jpg)
Modern Radiation Further Improves Survival in Non-Small Cell Lung Cancer: An Analysis of 288,670 Patients
![Overall survival of patients with EGFR mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland – real-world data Overall survival of patients with EGFR mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland – real-world data](https://www.archivesofmedicalscience.com/f/pictures/99749_28bf0.jpg)
Overall survival of patients with EGFR mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland – real-world data
Tumor Treating Fields Plus Standard of Care Improved Overall Survival Among Patients With Metastatic Non-Small Cell Lung Cancer on Vimeo
![Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug - Lung Cancer Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug - Lung Cancer](https://www.lungcancerjournal.info/cms/asset/5f6f926c-cc64-4071-b368-80631b38d7b7/gr1.jpg)
Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug - Lung Cancer
![Overall survival of 1466 non-small cell lung cancer patients according... | Download Scientific Diagram Overall survival of 1466 non-small cell lung cancer patients according... | Download Scientific Diagram](https://www.researchgate.net/publication/317189811/figure/fig3/AS:613891981709346@1523374662976/Overall-survival-of-1466-non-small-cell-lung-cancer-patients-according-to.png)
Overall survival of 1466 non-small cell lung cancer patients according... | Download Scientific Diagram
![Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer | British Journal of Cancer Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-019-0398-5/MediaObjects/41416_2019_398_Fig1_HTML.png)
Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer | British Journal of Cancer
![Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative | BMC Pulmonary Medicine | Full Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative | BMC Pulmonary Medicine | Full](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12890-020-01270-z/MediaObjects/12890_2020_1270_Fig4_HTML.png)
Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative | BMC Pulmonary Medicine | Full
![Overall survival by clinical stage according to the seventh edition (A)... | Download Scientific Diagram Overall survival by clinical stage according to the seventh edition (A)... | Download Scientific Diagram](https://www.researchgate.net/publication/288056727/figure/fig1/AS:624368539422720@1525872468049/Overall-survival-by-clinical-stage-according-to-the-seventh-edition-A-and-the-proposed.png)
Overall survival by clinical stage according to the seventh edition (A)... | Download Scientific Diagram
![VisualAbstract: Atezolizumab monotherapy superior to chemotherapy for treatment of non-small cell lung cancer | 2 Minute Medicine VisualAbstract: Atezolizumab monotherapy superior to chemotherapy for treatment of non-small cell lung cancer | 2 Minute Medicine](https://www.2minutemedicine.com/wp-content/uploads/2023/08/2MM_08.22.2023_1_Alisha_Lung.jpg)
VisualAbstract: Atezolizumab monotherapy superior to chemotherapy for treatment of non-small cell lung cancer | 2 Minute Medicine
![Cancers | Free Full-Text | Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre Cancers | Free Full-Text | Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre](https://pub.mdpi-res.com/cancers/cancers-15-01431/article_deploy/html/images/cancers-15-01431-g001.png?1677567641)
Cancers | Free Full-Text | Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre
![Postoperative Survival of Lung Cancer Patients: Are There Predictors beyond TNM? | Anticancer Research Postoperative Survival of Lung Cancer Patients: Are There Predictors beyond TNM? | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/33/4/1609/F1.large.jpg)
Postoperative Survival of Lung Cancer Patients: Are There Predictors beyond TNM? | Anticancer Research
![Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis | Radiation Oncology | Full Text Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis | Radiation Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13014-019-1222-3/MediaObjects/13014_2019_1222_Fig1_HTML.png)
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis | Radiation Oncology | Full Text
![Cancers | Free Full-Text | Immune Checkpoint Inhibitors after Radiation Therapy Improve Overall Survival Rates in Patients with Stage IV Lung Cancer Cancers | Free Full-Text | Immune Checkpoint Inhibitors after Radiation Therapy Improve Overall Survival Rates in Patients with Stage IV Lung Cancer](https://www.mdpi.com/cancers/cancers-15-04260/article_deploy/html/images/cancers-15-04260-g001.png)